The hexosamine signaling pathway: deciphering the "O-GlcNAc code"

Sci STKE. 2005 Nov 29;2005(312):re13. doi: 10.1126/stke.3122005re13.

Abstract

A dynamic cycle of addition and removal of O-linked N-acetylglucosamine (O-GlcNAc) at serine and threonine residues is emerging as a key regulator of nuclear and cytoplasmic protein activity. Like phosphorylation, protein O-GlcNAcylation dramatically alters the posttranslational fate and function of target proteins. Indeed, O-GlcNAcylation may compete with phosphorylation for certain Ser/Thr target sites. Like kinases and phosphatases, the enzymes of O-GlcNAc metabolism are highly compartmentalized and regulated. Yet, O-GlcNAc addition is subject to an additional and unique level of metabolic control. O-GlcNAc transfer is the terminal step in a "hexosamine signaling pathway" (HSP). In the HSP, levels of uridine 5'-diphosphate (UDP)-GlcNAc respond to nutrient excess to activate O-GlcNAcylation. Removal of O-GlcNAc may also be under similar metabolic regulation. Differentially targeted isoforms of the enzymes of O-GlcNAc metabolism allow the participation of O-GlcNAc in diverse intracellular functions. O-GlcNAc addition and removal are key to histone remodeling, transcription, proliferation, apoptosis, and proteasomal degradation. This nutrient-responsive signaling pathway also modulates important cellular pathways, including the insulin signaling cascade in animals and the gibberellin signaling pathway in plants. Alterations in O-GlcNAc metabolism are associated with various human diseases including diabetes mellitus and neurodegeneration. This review will focus on current approaches to deciphering the "O-GlcNAc code" in order to elucidate how O-GlcNAc participates in its diverse functions. This ongoing effort requires analysis of the enzymes of O-GlcNAc metabolism, their many targets, and how the O-GlcNAc modification may be regulated.

Publication types

  • Review

MeSH terms

  • Acetylglucosamine / analysis
  • Acetylglucosamine / physiology*
  • Acetylglucosaminidase / deficiency
  • Acetylglucosaminidase / genetics
  • Acetylglucosaminidase / physiology
  • Animals
  • Antigens, Neoplasm
  • Caenorhabditis elegans Proteins / physiology
  • Computational Biology
  • Diabetes Mellitus, Type 2 / genetics
  • Diabetes Mellitus, Type 2 / physiopathology
  • Genetic Predisposition to Disease
  • Hexosamines / physiology*
  • Histone Acetyltransferases / physiology
  • Humans
  • Hyaluronoglucosaminidase
  • Insulin Resistance
  • Intracellular Signaling Peptides and Proteins / physiology
  • Mammals
  • Mice
  • Mice, Transgenic
  • Multienzyme Complexes / physiology
  • N-Acetylglucosaminyltransferases / physiology
  • Neoplasm Proteins / deficiency
  • Neoplasm Proteins / genetics
  • Neoplasm Proteins / physiology
  • Neurodegenerative Diseases / physiopathology
  • Plant Proteins / physiology
  • Protein Processing, Post-Translational / physiology*
  • Signal Transduction / physiology*
  • Stress, Physiological / metabolism
  • Uridine Diphosphate N-Acetylglucosamine / physiology*
  • beta-N-Acetylhexosaminidases

Substances

  • Antigens, Neoplasm
  • Caenorhabditis elegans Proteins
  • Hexosamines
  • Intracellular Signaling Peptides and Proteins
  • Multienzyme Complexes
  • Neoplasm Proteins
  • Plant Proteins
  • Uridine Diphosphate N-Acetylglucosamine
  • Histone Acetyltransferases
  • N-Acetylglucosaminyltransferases
  • O-GlcNAc transferase
  • OGA protein, human
  • Hyaluronoglucosaminidase
  • hexosaminidase C
  • Acetylglucosaminidase
  • beta-N-Acetylhexosaminidases
  • Acetylglucosamine